Evidence map›Paper›PMID 25330784›Full record

ArticleAnnals of gastroenterology2014

Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study.

Haruhiro Inoue, Hiroaki Ito, Haruo Ikeda, Chiaki Sato, Hiroki Sato, Chainarong Phalanusitthepha, Bu'Hussain Hayee, Nikolas Eleftheriadis, Shin-Ei Kudo

4 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Annals of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 102 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03357809 nasuspendednot on this mapstarted 2017, after this paper: background citation

Monocentric Study Evaluating the Efficiency and Safety of Anti-reflux Mucosectomy ARMS for the Gastro-Esophageal Reflux Disease

TypeinterventionalSponsorHospital St. Joseph, Marseille, FranceRan2017 to 2023Enrolled15ConditionsGERD, Gastro Esophageal RefluxArmsEndoscopic mucosal resection
NCT03548298 nacompletednot on this mapstarted 2016, after this paper: background citation

Antireflux Ablation Therapy (ARAT) With Hybrid-APC (Argon Plasma Coagulation) for GERD Treatment in Patients Without Hiatal Hernia

TypeinterventionalSponsorCoordinación de Investigación en Salud, MexicoRan2016 to 2019Enrolled95ConditionsGastro Esophageal RefluxArmsARAT
NCT04036942 nawithdrawnnot on this mapstarted 2019, after this paper: background citation

Ablation Of The Esophagogastric Junction With Hybrid Argon Plasma Vs Mucosectomy With Band in Patients With Gastroesophageal Reflux Disease Without Hiatal Hernia

TypeinterventionalSponsorCoordinación de Investigación en Salud, MexicoRan2019 to 2025Enrolled0ConditionsGastroesophageal Reflux DiseaseArmsAblation of the gastroesophageal junction with hybrid argon plasma, mucosectomy with band of the gastroesophageal junction
NCT05570448 narecruitingnot on this mapstarted 2022, after this paper: background citation

Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)

TypeinterventionalSponsorMidwest Veterans' Biomedical Research FoundationRan2022 to 2027Enrolled36ConditionsGastro Esophageal RefluxArmsARAT, Sham intervention (control)
3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 1 synthesis or guideline pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Efficacy and safety of anti-reflux mucosal ablation therapy at 12 months.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2025
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Efficacy and Safety of Closure-Focused Anti-Reflux Mucoplasty Compared With Conventional ARMS: A Propensity Score-Matched Study (With Video).Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Haruhiro InoueDigestive Diseases Center, Showa University Koto-Toyosu Hospital, Tokyo, Japan (Haruhiro Inoue, Hiroaki Ito, Haruo Ikeda, Chiaki Sato, Hiroki Sato, P. Chainarong, Nikolas Eleftheriadis).
Hiroaki ItoDigestive Diseases Center, Showa University Koto-Toyosu Hospital, Tokyo, Japan (Haruhiro Inoue, Hiroaki Ito, Haruo Ikeda, Chiaki Sato, Hiroki Sato, P. Chainarong, Nikolas Eleftheriadis).
Haruo IkedaDigestive Diseases Center, Showa University Koto-Toyosu Hospital, Tokyo, Japan (Haruhiro Inoue, Hiroaki Ito, Haruo Ikeda, Chiaki Sato, Hiroki Sato, P. Chainarong, Nikolas Eleftheriadis).
Chiaki SatoDigestive Diseases Center, Showa University Koto-Toyosu Hospital, Tokyo, Japan (Haruhiro Inoue, Hiroaki Ito, Haruo Ikeda, Chiaki Sato, Hiroki Sato, P. Chainarong, Nikolas Eleftheriadis).
Hiroki SatoDigestive Diseases Center, Showa University Koto-Toyosu Hospital, Tokyo, Japan (Haruhiro Inoue, Hiroaki Ito, Haruo Ikeda, Chiaki Sato, Hiroki Sato, P. Chainarong, Nikolas Eleftheriadis).
Chainarong PhalanusitthephaDigestive Diseases Center, Showa University Koto-Toyosu Hospital, Tokyo, Japan (Haruhiro Inoue, Hiroaki Ito, Haruo Ikeda, Chiaki Sato, Hiroki Sato, P. Chainarong, Nikolas Eleftheriadis).
Bu'Hussain HayeeDepartment of Gastroenterology, King's College Hospital NHS Foundation Trust, London, UK (Bu'Hussain Hayee).
Nikolas EleftheriadisDigestive Diseases Center, Showa University Koto-Toyosu Hospital, Tokyo, Japan (Haruhiro Inoue, Hiroaki Ito, Haruo Ikeda, Chiaki Sato, Hiroki Sato, P. Chainarong, Nikolas Eleftheriadis).
Shin-Ei KudoDigestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan (Shin-ei Kudo).
Satou Hospital · JPKing's College Hospital NHS Foundation Trust · GBShowa University Northern Yokohama Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn our previous case report of circumferential mucosal resection for short-segment Barrett's esophagus with high-grade dysplasia, symptoms of gastro-esophageal reflux disease (GERD) were significantly improved. This observation suggests that anti-reflux mucosectomy (ARMS) could represent an effective anti-reflux procedure, with the advantage that no artificial devices or prostheses would be left

methodsIn this pilot study, 10 patients with treatment-refractory GERD received ARMS, 2 of whom circumferential, and the remaining 8 crescentic.

resultsKey symptoms of GERD improved significantly after ARMS. In the DeMeester score, mean heartburn score decreased from 2.7 to 0.3 (P=0.0011), regurgitation score from 2.5 to 0.3 (P=0.0022), and total score from 5.2 to 0.67 (P=0.0011). At endoscopic examination, the flap valve grade decreased from 3.2 to 1.2 (P=0.0152). In 24-h esophageal pH monitoring the fraction of time at pH <4 improved from 29.1% to 3.1% (P=0.1). Fraction time absorbance more than >0.14 of bile reflux was controlled from 52% to 4% (P=0.05). In 2 cases of total circumferential resection, repeat balloon dilation was necessary to control stenosis. In all cases, proton pump inhibitor prescription could be discontinued with no ill effects.

conclusionThis initial case series demonstrated the potential anti-reflux effect of ARMS, with a crescentic mucosal resection appearing adequate. Further longitudinal study of patients without sliding hiatus hernia will be required to establish ARMS as an effective technique to control GERD in this setting.

Indexed as

anti-reflux mucosectomyendoscopic treatmentGastroesophageal reflux disease

Identifiers

PMID25330784
PMCPMC4188931
OpenAlexW1522119501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.